Honestly, I am not sure that is a bad thing. I bought some more at .201 last week and can't buy anymore. But it is reasonable to think we will get a couple news items before the end of the year. One about the England research and (I hope) one about the FDA approval. Personally, I'd also like to know how the shareholder votes went. I have looked but not found any results.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.